Page last updated: 2024-10-27

fluconazole and Retroperitoneal Fibrosis

fluconazole has been researched along with Retroperitoneal Fibrosis in 1 studies

Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.

Retroperitoneal Fibrosis: A slowly progressive condition of unknown etiology, characterized by deposition of fibrous tissue in the retroperitoneal space compressing the ureters, great vessels, bile duct, and other structures. When associated with abdominal aortic aneurysm, it may be called chronic periaortitis or inflammatory perianeurysmal fibrosis.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alobaid, K1
Faty, M1
El-Nahas, A1
Al-Terki, A1
Khan, Z1

Reviews

1 review available for fluconazole and Retroperitoneal Fibrosis

ArticleYear
Renal fungus ball in a patient with retroperitoneal fibrosis: Unique complication in a rare disease.
    Mycoses, 2018, Volume: 61, Issue:6

    Topics: Adult; Antifungal Agents; Candida albicans; Candidiasis; Disease Management; Fluconazole; Humans; Ki

2018